Altimmune, Inc.
ALT
$4.06
-$0.02-0.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.75M | -90.24M | -95.06M | -103.52M | -101.35M |
| Total Depreciation and Amortization | 129.00K | 160.00K | 238.00K | 319.00K | -270.00K |
| Total Amortization of Deferred Charges | 58.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.32M | 11.13M | 10.50M | 22.25M | 22.87M |
| Change in Net Operating Assets | -4.33M | -1.39M | 4.48M | 2.84M | 7.26M |
| Cash from Operations | -81.57M | -80.33M | -79.85M | -78.12M | -71.49M |
| Capital Expenditure | -10.00K | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.85M | 6.03M | -28.39M | -49.98M | -46.77M |
| Cash from Investing | 110.84M | 6.03M | -28.39M | -49.98M | -46.77M |
| Total Debt Issued | 15.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 83.11M | 45.48M | 10.89M | 73.60M | 73.92M |
| Repurchase of Common Stock | -690.00K | -928.00K | -850.00K | -885.00K | -883.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -702.00K | -125.00K | -- | 0.00 | 0.00 |
| Cash from Financing | 96.71M | 44.42M | 10.04M | 72.71M | 73.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.98M | -29.87M | -98.19M | -55.38M | -45.22M |